What Sports Pharmacology Really Is: Boundaries, Categories and Risks
"Sports pharmacology" is a phrase used loosely in gyms and online, sometimes to mean vitamins, sometimes to mean anabolic steroids. The vagueness is not harmless: it blurs the line between a protein shake and a controlled substance. Our editorial team sets out a practical framework for what the term covers, how categories differ in law and risk, and why the boundaries matter.
Defining the field
In academic use, sports pharmacology studies how drugs affect exercise performance, recovery and adaptation, and how exercise changes the way drugs behave in the body. It also covers the treatment of athletes who have ordinary medical conditions such as asthma, hypertension or diabetes.
In popular use, the phrase usually means something narrower and more controversial: substances taken to improve physique or performance beyond what training and diet deliver. That includes anabolic-androgenic steroids, growth hormone, SARMs, peptides and stimulants.
A third meaning appears in clinical sports medicine: medicines used to protect health in athletes under heavy load, such as drugs for blood pressure or lipids. Here pharmacology is defensive rather than performance-driven.
Because the same phrase covers all three, discussions often talk past each other. Being explicit about which meaning is intended is the first step toward a useful conversation.
A workable classification
Rather than sorting substances by popularity, it helps to sort them by regulatory status and by what evidence exists.
| Category | Examples | US status | Evidence base |
|---|---|---|---|
| Nutrients and ergogenic supplements | Protein, creatine, caffeine, beta-alanine, nitrates | Dietary supplements under DSHEA | Moderate to strong for several |
| Supplements with weak evidence | Many herbal "boosters", exotic amino acids | Dietary supplements | Weak or absent |
| Prescription medicines | Testosterone, thyroid hormone, insulin, beta-blockers | Rx only; some are controlled substances | Strong for approved indications |
| Unapproved compounds | SARMs, many peptides, designer steroids | Not approved for human use | Limited; often preclinical only |
| Banned in sport | Anabolic agents, hormones, some stimulants, diuretics | Varies; on WADA Prohibited List | Irrelevant to eligibility |
Anabolic-androgenic steroids are Schedule III controlled substances in the United States under the Anabolic Steroid Control Act, which means non-prescribed possession or distribution is a criminal matter, independent of sport rules.
SARMs occupy a different space: they are not approved drugs, and the FDA has issued warnings about products sold as "research chemicals" or labeled as supplements. Selling them as dietary supplements is unlawful.
WADA's Prohibited List, updated annually, governs eligibility for tested athletes. Something can be legal to possess and still cost an athlete a sanction, and vice versa.
Where the evidence actually is
The International Society of Sports Nutrition and the IOC consensus statement (Maughan et al., 2018) identify a short list of supplements with reasonable support: creatine monohydrate, caffeine, beta-alanine, dietary nitrate and bicarbonate, plus protein and carbohydrate as nutrition fundamentals.
Prescription hormones can increase muscle mass. The classic trial by Bhasin et al. (1996) showed that supraphysiologic testosterone plus training increased muscle size and strength more than training alone. That is a documented pharmacological effect, not a myth.
What those studies do not show is safety for long-term non-medical use. The Endocrine Society scientific statement (Pope et al., 2014) catalogued cardiovascular, endocrine, hepatic and psychiatric harms associated with performance-enhancing drug use.
For SARMs and most peptides, human data are thin. Case reports and series have described liver injury and hormonal suppression linked to SARM products, including documented cases of drug-induced liver injury.
The risk picture
Risk in this field is not uniform. It depends on the substance, the dose, the duration, the user's health and the quality of the product.
- Cardiovascular: adverse lipid changes, hypertension, cardiac remodeling and increased thrombotic risk with androgens.
- Endocrine: suppression of the hypothalamic-pituitary-gonadal axis, infertility, gynecomastia; in women, irreversible virilization.
- Hepatic: liver injury, especially with oral 17-alpha-alkylated steroids and some SARM products.
- Psychiatric: irritability, aggression, mood disorders and dependence patterns.
- Acute medical danger: metabolic agents such as insulin or DNP can cause death; these are not in the same risk class as a protein powder.
- Product quality: unregulated sources frequently contain wrong doses, wrong substances or contaminants.
- Legal and career: criminal exposure, loss of eligibility, loss of scholarships or employment.
Risk also stacks. Combining several agents, as is common in non-medical use, multiplies unknowns and makes it difficult to attribute a problem to any single cause.
Age matters too. Adolescents are especially vulnerable, since androgens can affect growth plate closure and brain development.
Drawing boundaries that help in practice
A useful personal framework starts with questions rather than substances. Is this a food, a supplement with evidence, a prescribed medicine or an unapproved compound? Who supervises it? What is being monitored?
For most people, performance is limited by training consistency, sleep, protein intake and total calories, not by pharmacology. Those factors have no legal risk and strong evidence behind them.
Athletes subject to testing should check every product against current anti-doping rules and use certified supplements. US Anti-Doping Agency resources and the Global DRO database exist for exactly this purpose.
Anyone who is already using or considering performance drugs is better served by a frank conversation with a physician than by forum advice. Baseline labs, blood pressure checks and honest discussion of goals reduce harm even when the answer is not what the user hoped to hear.
Clear categories also help readers evaluate information. An article that mixes creatine and insulin into one list called "sports pharma" is not describing one topic; it is describing several with very different stakes.
Conclusions of the editorial team
Sports pharmacology spans everyday nutrition, evidence-based supplements, legitimate prescription medicine and unapproved performance drugs, and these categories carry very different risks.
US law, FDA regulation and the WADA Prohibited List are three separate systems; a substance can be legal and banned, or prohibited and still widely sold online.
The evidence for performance gains from hormones is real, but so is the documented harm, and product quality in unregulated markets is a risk in itself.
For deeper reading, see our materials on evidence-based supplements with proven effects, baseline blood tests for athletes, and how counterfeit products reach the market.
References
- Maughan RJ, Burke LM, Dvorak J, et al. IOC consensus statement: dietary supplements and the high-performance athlete. Br J Sports Med. 2018;52(7):439–455.
- Kerksick CM, Wilborn CD, Roberts MD, et al. ISSN exercise & sports nutrition review update: research & recommendations. J Int Soc Sports Nutr. 2018;15(1):38.
- Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335(1):1–7.
- Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341–375.
- Van Wagoner RM, Eichner A, Bhasin S, Deuster PA, Eichner D. Chemical composition and labeling of substances marketed as selective androgen receptor modulators and sold via the internet. JAMA. 2017;318(20):2004–2010.
- Kanayama G, Hudson JI, Pope HG Jr. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend. 2008;98(1–2):1–12.
